Why InVivo Therapeutics Shares Are Skyrocketing
InVivo Therapeutics shares absolutely skyrocketed on Wednesday after the firm provided an update on results from the company’s single-arm INSPIRE study.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 136
Analysts Show More Caution Toward Gilead’s Mystical Recovery
Gilead Science was supposed to be coming back as a company on the heels of its first major acquisition in years. Unfortunately, the post-earnings reaction has not been any help on that front.
Can Esperion Therapeutics Go the Distance After This Report?
Esperion Therapeutics released its first-quarter financial results and a business update before the markets opened on Wednesday.
Why Gilead Sciences Whiffed in Q1
Gilead Sciences released disappointing first-quarter financial results late Tuesday and shares tumbled early Wednesday.
Many Face Difficult Summer as Mosquitoes and Ticks Surge
In some parts of the country, infestations of dangerous mosquitoes, ticks and fleas will make the outdoor activity risky, according to the CDC.
Why Karyopharm Is on the Move
Karyopharm Therapeutics saw its shares make a handy gain on Tuesday after the firm announced positive top-line results from the Phase 2b STORM study evaluating selinexor.
Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?
Regeneron Pharmaceuticals and Sanofi are committing to lowering the price of the anti-cholesterol drug Praluent.
Will Gilead Sciences Earnings Get a Boost From a Collaboration?
Gilead Sciences is set to report its most recent quarterly results after the markets close on Tuesday, the first since an announced collaboration with Sangamo Therapeutics.
Why One Old Stock Buyback Trick Is Working So Well for AbbVie
AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch tender auction.
How Keytruda Saved Merck’s Q1
Merck released better-than-expected quarterly results and full-year guidance before the markets opened on Tuesday.
How Much Pfizer Earnings Depend on a Few Brands
Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.
What to Look For in the Merck and Pfizer Reports Tuesday Morning
Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These are the two biggest companies in the pharma industry and they can set the…
Evelo Announces Potential Pricing for IPO
Evelo Biosciences expects to price its more than 5 million shares in a range that results in an initial public offering valued up to almost $104 million.
Why SteadyMed Shares Are Skyrocketing
SteadyMed saw its shares skyrocket early on Monday after the company announced that it would be acquired by United Therapeutic.
Johnson & Johnson Commits to Yet Another Dividend Hike
Johnson & Johnson just delivered yet another dividend hike. The company previously had committed to increasing its dividends over and over.